BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 18, 2005
View Archived Issues
Antithrombotic efficacy of dual-acting MC-45308
Read More
Oxytocin receptor antagonists in the prevention of preterm labor
Read More
Renal impairment does not significantly affect the PK profile of oral naftidrofuryl
Read More
Anticoagulant and antiinflammatory effects of rhAT in healthy volunteers
Read More
Darifenacin improves quality of life of patients with overactive bladder
Read More
Recent patents cover novel treatments for cognitive disorders
Read More
Novel antiglaucoma agents jointly disclosed by Ube and Santen
Read More
Vanilloid VR1 receptor modulators emerge from recent R&D
Read More
Antiviral efficacy and pharmacokinetics of single-oral dose PA-457 reported in HIV-infected patients
Read More
Antiviral efficacy and pharmacokinetics of vicriviroc alone or in combination with other antivirals
Read More
Thiovir effective against resistant HIV-1 strains and synergistic with zidovudine
Read More
ImClone Systems and UCB enter partnership for CDP-791
Read More
Vicuron stockholders vote to approve acquisition by Pfizer
Read More
Dosing begins in phase I study of GS-9132 for HCV
Read More
Vaqta approved for children as young as 12 months of age
Read More
Pfizer completes acquisition of Bioren
Read More
Astellas reports discovery of novel reverse NCX inhibitor YM-270951
Read More
Predix begins pivotal study with PRX-00023 for generalized anxiety disorder
Read More
Akorn signs agreement for AK-1015
Read More
Alnylam awarded grant for Parkinson's research
Read More
Positive phase III results for Desilux
Read More
Migenix cleared to begin phase IIb study of MX-3253 in Canada
Read More
HuMax-CD20 enters phase II study for rheumatoid arthritis
Read More
Schering-Plough exercises rights to CNTO-148
Read More
Japanese approval for Amplatzer Septal Occluder for atrial septal occlusion
Read More
Promising preliminary results for HER-2 Protein AutoVac in breast cancer
Read More
Otsuka to launch Meptin Clickhaler in Japan
Read More